🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

The Third Affiliated hospital of Zhejiang Chinese Medical University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with The Third Affiliated hospital of Zhejiang Chinese Medical University as lead sponsor. Synced 26 Sep 2026
14Current trials
11Recruiting now
2Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

The Third Affiliated hospital of Zhejiang Chinese Medical University is the lead sponsor of 14 current clinical trials in our China register. 11 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Amitriptyline and Paclitaxel. The most-studied condition is Lumbar Disc Herniation.

ClinicalTrials.gov trials by status

  • Recruiting1179%
  • Not yet open321%

Trials by phase

  • Not applicable1071%
  • Phase 317%
  • Phase 417%
  • Phase 217%
  • Observational17%
01

Clinical trials sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University

14 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
EA for BPS: An RCT and Study for Central Mechanism
NCT05279963 · ClinicalTrials.gov ↗ · Bladder Pain Syndrome
Not applicable Recruiting 2022-03 China
Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia
NCT05431010 · ClinicalTrials.gov ↗ · Sarcopenia
Not applicable Recruiting 2022-07 China
Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain
NCT07308951 · ClinicalTrials.gov ↗ · Quality of Life, Chronic Cancer Pain
Not applicable Recruiting 2025-09 China
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
NCT06330337 · ClinicalTrials.gov ↗ · Glioma
Phase 3 Recruiting 2024-04 China
A Biomechanical Study of the Lumbar Intervertebral Disc by Lever Positioning Manipulation
NCT06872918 · ClinicalTrials.gov ↗ · Lumbar Disc Herniation
Not applicable Recruiting 2024-01 China
Peripheral-central Correlation Study on the Treatment of Chronic Tinnitus With "Dao qi Tong Luo" Based on the Theory of "Connecting the Two Ears to the Brain"
NCT06401993 · ClinicalTrials.gov ↗ · Tinnitus
Not applicable Recruiting 2024-05 China
Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial
NCT06737549 · ClinicalTrials.gov ↗ · Ischemic Stroke, Dysphagia
Phase 4 Recruiting 2024-12 China
Clinical Evaluation of Surrounding Electroacupuncture in the Treatment of Acute Lateral Ankle Sprain
NCT06182943 · ClinicalTrials.gov ↗ · Electroacupuncture
Not applicable Recruiting 2023-11 China
Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial
NCT06818331 · ClinicalTrials.gov ↗ · Glioma
Phase 2 Recruiting 2025-02 China
Application of Machine Learning Based on fNIRS in Predicting Acupuncture's Efficacy in Treating Tinnitus
NCT06364670 · ClinicalTrials.gov ↗ · Tinnitus
Not applicable Recruiting 2024-05 China
Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms
NCT07250308 · ClinicalTrials.gov ↗ · Functional Dyspepsia, Chronic Atrophic Gastritis (CAG)
Observational Recruiting 2025-10 China
Brain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI
NCT07728149 · ClinicalTrials.gov ↗ · Lumbar Disc Herniation
Not applicable Not yet open 2026-07 China
Efficacy Evaluation of Electroacupuncture in the Treatment of Functional Dyspepsia
NCT07496580 · ClinicalTrials.gov ↗ · Functional Dyspepsia, Electroacupuncture
Not applicable Not yet open 2026-03 China
Biomechanical Study of Lever Positioning Manipulation on Scoliosis
NCT07325045 · ClinicalTrials.gov ↗ · Scoliosis
Not applicable Not yet open 2026-01 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in The Third Affiliated hospital of Zhejiang Chinese Medical University trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in The Third Affiliated hospital of Zhejiang Chinese Medical University trials

13 conditions
Lumbar Disc Herniation2Glioma2Tinnitus2Electroacupuncture2Functional Dyspepsia2Bladder Pain Syndrome1Sarcopenia1Quality of Life1Chronic Cancer Pain1Ischemic Stroke1Dysphagia1Scoliosis1Chronic Atrophic Gastritis (CAG)1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China1411

A trial with sites in more than one country appears in each of those registers.

05

Questions about The Third Affiliated hospital of Zhejiang Chinese Medical University trials

How many clinical trials does The Third Affiliated hospital of Zhejiang Chinese Medical University sponsor?

The Third Affiliated hospital of Zhejiang Chinese Medical University is the lead sponsor of 14 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are The Third Affiliated hospital of Zhejiang Chinese Medical University trials recruiting?

Yes. 11 of its 14 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is The Third Affiliated hospital of Zhejiang Chinese Medical University testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Amitriptyline (1) and Paclitaxel (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.